Assessment of ocrelizumab impact on neurofilament levels in multiple sclerosis patients
Assessment of ocrelizumab impact on neurofilament levels in multiple sclerosis patients
About this item
Full title
Author / Creator
Publisher
Târgu Mureș: Sciendo
Journal title
Language
English
Formats
Publication information
Publisher
Târgu Mureș: Sciendo
Subjects
More information
Scope and Contents
Contents
NOABSTRACTMultiple sclerosis (MS) is a debilitating neurological disease characterized by inflammation, demyelination, and neurodegeneration in the central nervous system. Despite extensive research, the pathology of MS remains incompletely understood. Ocrelizumab (OCRE), a monoclonal antibody targeting CD20-positive B cells, has shown efficacy in...
Alternative Titles
Full title
Assessment of ocrelizumab impact on neurofilament levels in multiple sclerosis patients
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_5ca210c4947f4e94882b1ceb14d459a7
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_5ca210c4947f4e94882b1ceb14d459a7
Other Identifiers
ISSN
2284-5623,1841-6624
E-ISSN
2284-5623
DOI
10.2478/rrlm-2024-0019
